Stock Of The Day: TG Therapeutics Breaks Out, May Head Higher TG Therapeutics has broken an important resistance level. There is a good chance that they will continue to move higher.
TG THERAPEUTICS INC (NASDAQ:TGTX), a growth stock which is not overvalued. Uncover the potential of TG THERAPEUTICS INC, a growth stock reasonably priced. NASDAQ:TGTX is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation.
Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? Top mid-cap stocks jumped up to 23.87%. Some reasons include strong gold/silver, better financial results, and market strength.
Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week Annual revenue from its MS drug, Briumvi, more than tripled, with U.S. net product revenue reaching $103.6 million in the fourth quarter and $310 million for the full year.
Stocks Pivot Lower On Trade Fears, Manufacturing Data Despite earlier indicating a strong start to March, stocks are lower this afternoon amid trade war concerns.
What's Going On With TG Therapeutics Stock Tuesday? TG Therapeutics Inc (
NASDAQ:TGTX ) shares are trading higher. The company on Tuesday provided guidance for the fourth quarter and full-year 2024.
TG Therapeutics Crashes — Reversing A Breakout — On Its Mixed Third-Quarter Results The company raised its sales outlook for the year, though, following stronger-than-expected revenue from its only product.
AI Stocks Meta, Oracle Lead Five Names Near Buy Points Two of the 5 top stocks to watch this week tap the artificial intelligence market.
